[Federal Register Volume 68, Number 58 (Wednesday, March 26, 2003)]
[Notices]
[Page 14672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7151]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, SEP--Ancillary Pharmacogenetics Studies in 
Heart, Lung, Blood and Sleep Disorders.
    Date: May 12, 2003.
    Time: 8:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Judy S. Hannah, Scientific Review Administrator, 
Review Branch, Division of Extramural Affairs, National Heart, Lung, 
and Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7190, Bethesda, MD 20892. 301/435-0287.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: March 18, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-7151 Filed 3-25-03; 8:45 am]
BILLING CODE 4140-01-M